AMRX stock · AAPL stock · Lician Pro · $19.99/mo or $149/yr
AMRX vs AAPL · P/E 40, rev $3.02B vs P/E 39, rev $416.16B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported AMRX revenue for 2025-12-31 was $3.02B. Net income was $72.1M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 40.0.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.4.
AMRX currently screens at market cap $5.19B and trailing P/E 40.0. AAPL currently screens at market cap $3.83T and trailing P/E 39.4.
Not investment advice. Open the AMRX and AAPL stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | AMRX | AAPL |
|---|---|---|
| Price | $19.18 | $343.46 |
| Market cap | $5.19B | $3.83T |
| Trailing P/E | 40.0 | 39.4 |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | AMRX | AAPL |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
AMRX vs AAPL comparison FAQ
What is AMRX's market cap?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) currently screens at market cap $5.19B.
What is AAPL's market cap?
Apple Inc (AAPL) currently screens at market cap $3.83T.
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) screens at trailing P/E 40.0.
What is AAPL's P/E ratio?
Apple Inc (AAPL) screens at trailing P/E 39.4.
What is AMRX's latest revenue?
Latest reported AMRX revenue for 2025-12-31 was $3.02B.
What is AAPL's latest revenue?
Latest reported AAPL revenue for 2025-09-27 was $416.16B.
What is AMRX's net income?
Net income was $72.1M for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX).
Where is the AMRX vs AAPL comparison listed?
The cached AMRX vs AAPL comparison is listed at https://lician.com/compare/amrx-vs-aapl.
Not investment advice.